6-Ethylchenodeoxycholic-d5 Acid (Ethyl-D5)

6-Ethylchenodeoxycholic-d5 Acid is a deuterated derivative of 6-Ethylchenodeoxycholic Acid (6-ECDCA), a bile acid naturally produced in the liver to aid in the digestion and absorption of dietary fats. The deuterium labeling is used for research purposes to track the fate of the molecule in biological systems. In terms of chemical information, 6-ECDCA is a cholic acid derivative with a hydroxyl group at position 3 and 7, a carboxyl group at position 24, and a methyl group at position 18. The addition of five deuterium atoms in 6-Ethylchenodeoxycholic-d5 Acid does not significantly alter its chemical properties. 6-ECDCA and its derivatives have been studied for their potential therapeutic effects on various diseases such as non-alcoholic fatty liver disease, diabetes, and metabolic syndrome. It has been shown to improve insulin sensitivity and reduce hepatic fat accumulation in animal models. In addition, 6-ECDCA has anti-inflammatory properties that may be beneficial in treating inflammatory bowel disease and other inflammatory conditions. Overall, 6-Ethylchenodeoxycholic-d5 Acid is a valuable tool for researchers studying the pharmacokinetics and pharmacodynamics of bile acids and their derivatives. Its potential therapeutic effects make it a promising candidate for further research in the treatment of metabolic disorders and inflammatory diseases.